Norbe Todd 4
4 · BIOLASE, INC · Filed Jul 23, 2020
Insider Transaction Report
Form 4
BIOLASE, INCBIOL
Norbe Todd
DirectorPresident and CEO
Transactions
- Award
Series F Convertible Preferred
2020-07-22+3→ 3 totalExercise: $0.40From: 2020-07-22→ Common Stock - Award
Warrants
2020-07-22+7,500→ 7,500 totalExercise: $0.40From: 2020-07-22Exp: 2025-07-22→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]An investment of $1,000 in the Issuer's rights offering provided the Reporting Person with one share of Series E Preferred Stock and 2,500 Warrants, which are the subject securities reported by the Reporting Person in this Form 4.
- [F2]Each share of Series F Preferred Stock will be convertible at the Issuer's option at any time on or after July 15, 2021 or at the option of the Reporting Person at any time, into the number of shares of the Issuer's common stock determined by dividing the $1,000 stated value per share of the Series E Preferred Stock by a Conversion Price of $0.40 per share.